FIBROBLAST GROWTH FACTOR-23 AND HYPOVITAMINAEMIA D IN ANAEMIA OF TYPE 2 DIABETIC NEPHROPATHY Grigorios G. Dimas 1, Fotios S. Iliadis 1, Ilias E. Kanellos.

Slides:

Advertisements

Similar presentations

Diabetes, Anemia and Chronic Kidney Disease Josephine Carlos-Raboca,M.D., F.P.S.E.M., Endocrinology, Diabetes and Metabolism Makati Medical Center.

Advertisements

Role of Vitamin D in Blood Malignancies Dr Imran Hilal.

Uncontrolled secondary hyperparathyroidism in a haemodialysis patient Jordi Bover, MD, PhD Fundació Puigvert Barcelona, Spain © Springer Healthcare, a.

KIDNEY FOUNDATION MISSION St. Gregorios Dayabhavan Kunigal.

Neel Bhalala (2009) Sofia Medical University. Background  Erythropoiesis-stimulating agents are man-made versions of a natural protein known as erythropoietin.

G.N. Dalekos3, M. Elisaf2, A.I. Hatzitolios1

Chronic Kidney Disease Workshop Maarten Taal Department of Renal Medicine Derby City General Hospital Derby Nephrology Research.

Mugendi AG, BPharm, MPharm (Clin Pharm). Comparison of the effects of losartan and enalapril on renal function in adults with chronic kidney disease at.

Grigorios G. Dimas1, Thomas J. Tegos2, Fotios S. Iliadis1, Ilias E

Chronic Kidney Disease

Reference Cooper BA, and the IDEAL study group. A randomized controlled trial of early versus late initiation of dialysis. N Engl J Med [Accessed.

Use of clinical laboratory databases to enable early identification of patients at highest risk of developing end- stage kidney disease Dr David Kennedy.

NKF-KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease UPDATE OF HEMOGLOBIN TARGET Am.J.Kidney.Dis.

RENAL DISEASE IN DIABETES

Non-Surgical Periodontal Therapy Reduces Coronary Heart Disease Risk Markers: A Randomized Controlled Trial Bokhari SAH, Khan AA, Butt AK, Azhar M, Hanif.

SERUM VISFATIN CONCENTRATION IS ASSOCIATED WITH AN ATHEROGENIC METABOLIC PROFILE T.D. Filippatos 1, A. Liontos 1, F. Barkas 1, E. Klouras 1, V. Tsimihodimos.

INTRODUCTION Dysregulation of Hypothalamic-Pituitary-Adrenal, (HPA), axis has been hypothesized to participate in the emergence of psychosis, yet findings.

Stage 4 CKD presentation in patients over 75 Years Old differs from that in patients less than 75 Years of Age Hiromichi Suzuki, Tsutomu Inoue,Tomohiro.

INTRODUCTION During last decades much evidence has been accumulated concerning the neuroendocrine aetiopathological basis of schizophrenia. Recently research.

INTRODUCTION The stress diathesis hypothesis of psychosis is one of the most prevailing models of the aetiopathology of psychotic disorders. Cortisol is.

Mrs. Watcharasa Pitug ID The Association between Waist Circumference and Renal Insufficiency among Hypertensive Patients 15/10/58 1.

INCREASED CIRCULATING SERUM LEVELS OF MMP-9 AND VEGF-A ARE ASSOCIATED WITH OXIDATIVE STRESS IN PATIENTS WITH PRIMARY GLOMERULONEPHRITIS AND EARLY STAGES.

Mrs. Watcharasa Pitug ID The Association between Waist Circumference and Renal Insufficiency among Hypertensive Patients 20/10/58 1.

SERUM LEVELS OF IGF-1 IN FIRST EPISODE PSYCHOSIS AND CHRONIC SCHIZOPHRENIA PATIENTS COMPARED TO HEALTHY CONTROLS E. Ntouros 1, E. Karanikas 1, P. Ntafoulis.

ASSOCIATION OF CIRCULATING SERUM LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR-A WITH VASCULAR ULTRASOUND DETERMINANTS OF DEMENTIA IN PATIENTS WITH TYPE.

ASSOCIATION OF HYPOVITAMINAEMIA D AND TRANSFORMING GROWTH FACTOR – β1 IN THE PROGRESSION OF CHRONIC KIDNEY DISEASE Grigorios G. Dimas 1, Ilias E. Kanellos.

X-Linked hypophosphatemic rickets (XLH), caused by mutations in PHEX, is the most common inherited disorder of renal phosphate wasting. The PHEX mutation.

INCREASED CIRCULATING SERUM LEVELS OF TGFβ-1 AND IL-6 ARE ASSOCIATED WITH THE PROGRESSION OF CΗRONIC KIDNEY DISEASE IN ATHEROSCLEROTIC PATIENTS WITH TYPE.

MiR-21 can be used as independent prognostic factor for survival and metastasis in urinary bladder cancer. Apostolos Zaravinos 1, Jelena Radojicic 3, George.

Mrs. Watcharasa Pitug ID The Association between Waist-to-Hight ratio, waist circumference,and Body Mass Index as Risk Factors for Chronic.

SERUM LEVELS OF TISSUE INHIBITOR OF METALLOPROTEINASE-2 AND OX-LDL ARE ASSOCIATED WITH ATHEROSCLEROSIS IN PATIENTS WITH CΗRONIC KIDNEY DISEASE Grigorios.

ANTIPLATELET TREATMENT IN PATIENTS WHO HAVE AN ISCHEMIC STROKE WHILE TAKING ASPIRIN Konstantinos Tziomalos, Stella D. Bouziana, Marianna Spanou, Stavroula.

Dietary Issues in Renal Complications Ulrich Wahl, Tamworth, 2010.

Parks and Chronic Disease Management ●Diabetic individuals taking 30-minute walks in a forest experienced much lower blood glucose levels than the same.

The Role of Insulin- Like Growth Factor-1 in Schizophrenia By Karen Kiernan.

Comparison of Asymmetric DimethylArginine Levels and Coronary Artery Calcifications in Different Stages of Chronic Kidney Disease and Kidney Transplantation.

Increased Circulating Levels of Betatrophin in Newly Diagnosed Type 2 Diabetic Patients Featured Article: Hao Hu, Wenjun Sun, Shuqin Yu, Xiafei Hong, Weiyun.

INCREASED CIRCULATING SERUM LEVELS OF TGFβ-1 AND MMP-2 ARE ASSOCIATED WITH INFLAMMATION AND PROGRESSION OF CΗRONIC KIDNEY DISEASE IN PATIENTS WITH TYPE.

Expression profile of oncomiRs and tumor-suppressor miRs in urothelial carcinoma of the bladder Apostolos Zaravinos 1, George I. Lambrou 2, Jelena Radojicic.

INCREASED CIRCULATING SERUM LEVELS OF VEGF-A ARE ASSOCIATED WITH ALBUMINURIA IN HYPETENSIVE PATIENTS Grigorios G. Dimas 1, Thomas J. Tegos 2, Ilias E.

DIABETES MELITUS, HYPERTENSION AND PARKINSON DISEASE IN A COMMON THREE LEAF CLOVER NEURODEGENERATIVE PATHWAY Grigorios G. Dimas 1, Charikleia T. Sachinidou.

High Coronary Calcification Scores Predict Mortality in Pre-Dialysis CKD Patients Reference: Haas MH. The risk of death in patients with a high coronary.

Vitamin D: A New Frontier in Diabetes Management Contact Information: Background Acknowledgement Methods.

Vitamin D deficiency and anemia in early chronic kidney disease 2010/05/18 R4 이완수 2010.

The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.

Introduction Conclusions Liver transplant recipients with impaired renal function or a low dose-adjusted tacrolimus concentration suggesting a high CYP3A4.

The DVD Trial. Source Reinecke H, Fobker M, Wellmann J, et al. A randomized controlled trial comparing hydration therapy to additional hemodialysis or.

The SYMPHONY Trial Reference Reddan DN, et al. Renal function, concomitant medication use and outcomes following acute coronary syndromes. Nephrol Dial.

The CHART-2 Study (The Chronic Heart Failure Analysis and Registry in the Tohoku District 2) Source Shiba N, Nochioka K, Miura M, et al. Trend of westernization.

RELATIONSHIP BETWEEN PARATHYROID HORMONE, VITAMIN-D, CALCIUM AND PHOSPHORUS IN CKD Neeraja Kunireddy, Priscilla Abraham Chandran, Sree Bhushan Raju, M.Noorjahan.

Soluble Klotho Pretreatment Improves Endothelial Dysfunction Induced By FGF23 Halee Patel, Neerupma Silswal, and Michael Wacker UMKC School of Medicine,

The FRACTURE Study (Ongoing). Source West SL, Lok CE, Jamal SA. Fracture Risk Assessment in Chronic Kidney Disease, Prospective Testing Under Real World.

Serum Dickkopf-1 ( DKK-1) and Arthritis in Systemic Lupus Erythematosus Patients S. I. Nasef, H. H. Omar Samah Ismail Nasef MD, MRCP Rheumatology UK Lecturer.

Prevalence of Chronic Kidney Disease among Older Adults in Urban Sri Lanka - Tip of the Iceberg? S T De Silva1,2, K T A A Kasturiratna3, S Chackrewarthy4.

3Neonatology, University of Miami, Miami, FL, USA

－ Higher SBP visit-to-visit variability (SBV) has been associated

The LIVES Sub-analysis

Contribution of Oxidized Low Density Lipoprotein and Nitric Oxide in the Pathogenesis of Early Onset Acute Myocardial Infarction in Egyptian population.

CORRELATION OF BIOMARKERS FOR AXONAL DEGENERATION WITH RETINAL NERVE FIBER LAYER THICKNESS AND DISABILITY IN DIFFERENT PHASES OF MULTIPLE SCLEROSIS UZUNKOPRU.

Katarzyna Jobs, Anna Jung

Prevalence of Chronic Kidney Disease among Older Adults in Urban Sri Lanka - Tip of the Iceberg? S T De Silva1,2, K T A A Kasturiratna3, S Chackrewarthy4.

EMPHASIS-HF Extended Follow-up

Advancing Management of Anemia With the Latest Data From ERA-EDTA 2018

Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD Figure 3 | Energy metabolism regulation, cardiovascular and bone disease.

FGF23 or PTH: which comes first in CKD ?

Yasuhiro Hamada, Masafumi Fukagawa Kidney International

Volume 79, Pages S20-S23 (April 2011)

Use of vitamin D in chronic kidney disease patients

Mineral metabolism in CKD: adaptation devolves into maladaptation.

Scientific Inquiry AIM: Students will understand the basic principles behind scientific inquiry. DO NOW: Write down the best definition of ‘science’ that.

Presentation transcript:

FIBROBLAST GROWTH FACTOR-23 AND HYPOVITAMINAEMIA D IN ANAEMIA OF TYPE 2 DIABETIC NEPHROPATHY Grigorios G. Dimas 1, Fotios S. Iliadis 1, Ilias E. Kanellos 1, Thomas J. Tegos 2, Sofia G. Spiroglou 3, Spiros D. Fotiadis 1, Ioannis M. Karamouzis 1, Christos G Savopoulos 1, Apostolos I. Hatzitolios 1, Dimitrios M. Grekas st Propaedeutic Medical Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece 2 1 st Neurology Medical Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece 3 Biochemistry Laboratory, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece

Background Clinical and experimental evidence support a role for fibroblast growth factor (FGF-23) in promoting osteoclastic bone resorption, but the precise molecular mechanisms are not yet fully understood. FGF-23 has been implicated in chronic kidney disease (CKD) and is important in humans for osteogenesis. The role of vitamin D in type 2 diabetes is well recognized, but its relation to glucose metabolism is not well studied. The observation that anaemia begins in diabetic nephropathy (DN) before the other causes of CKD leaded us to investigate this hypothesis.

Aim The aim of the present study was to determine the serum levels of FGF-23 and 1.25(OH) 2 D 3 and to investigate their potential correlation with anaemia, in early stages of CKD and type 2 DN.

Methods CKD patients of stages 1 and 2 with type II DN (n=50) were included. As controls, there were healthy individuals (n=40). 1.25(OH) 2 D 3 and FGF-23 levels were measured by an ELISA method.

Results The levels of 1.25(OH) 2 D 3 were significantly higher in patients than in the control groups (40±3, p<0.0001), FGF-23 were significantly higher in patients (0.5±0.1, p<0.004) and hemoglobin (Hb) was (4±1, p<0.005). There was negative strong correlation between FGF-23 and 1.25(OH) 2 D 3 (r= -0.75, p<0.005) such as FGF-23 and Hb (r= -0.7, p<0.005). There was positive strong correlation between 1.25(OH) 2 D 3 and Hb (r= 0.7, p<

Conclusion This study suggests that serum levels of FGF-23 and 1.25(OH) 2 D 3 were found to be independent risk factors of anaemia in early stages of type II diabetic nephropathy.